DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Kwo P, Gitlin N, Nahass R. , et al.
Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study.
Hepatology 2016;
64 (02) 370-380
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.